On September 10, 2020 Oncternal Therapeutics (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, reported that management will participate in the following conferences in the month of September and invites investors to join by webcast (Press release, Oncternal Therapeutics, SEP 10, 2020, View Source [SID1234564959]). Please see additional details below:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 22nd Annual Global Investment Conference (Virtual)

Title:
Oncternal Therapeutics (ONCT) Company Presentation

Date:

Wednesday, September 16th, 2020

Time:

10:30 am Eastern Time

Presenter:

James Breitmeyer, President & CEO

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual)

Title:

Oncternal Therapeutics (ONCT) Company Presentation

Date:

Tuesday, September 22nd, 2020

Time:

4:10 pm Eastern Time

Presenter:

James Breitmeyer, President & CEO

Webcast Links:

Live webcasts of the presentations will be available online via a link from the investor relations page of the Company’s website at View Source, and the webcasts will be archived there for at least 30 days following the events.